ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $360,000 | +77.3% | 4,001 | +4.5% | 0.02% | +122.2% |
| Q4 2019 | $203,000 | +34.4% | 3,829 | 0.0% | 0.01% | +28.6% |
| Q3 2019 | $151,000 | -3.8% | 3,829 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $157,000 | -6.0% | 3,829 | +6.6% | 0.01% | -12.5% |
| Q1 2019 | $167,000 | +17.6% | 3,593 | +10.5% | 0.01% | 0.0% |
| Q4 2018 | $142,000 | -23.7% | 3,252 | 0.0% | 0.01% | -11.1% |
| Q3 2018 | $186,000 | +17.7% | 3,252 | 0.0% | 0.01% | +12.5% |
| Q2 2018 | $158,000 | +24.4% | 3,252 | 0.0% | 0.01% | +33.3% |
| Q1 2018 | $127,000 | -8.0% | 3,252 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $138,000 | +26.6% | 3,252 | +15.6% | 0.01% | +20.0% |
| Q3 2017 | $109,000 | +28.2% | 2,813 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $85,000 | +34.9% | 2,813 | +18.8% | 0.00% | +33.3% |
| Q1 2017 | $63,000 | – | 2,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |